Egr-1 transcriptionally activates protein phosphatase PTP1B to facilitate hyperinsulinemia-induced insulin resistance in the liver in type 2 diabetes
Egr-1 transcriptionally activates protein phosphatase PTP1B to facilitate hyperinsulinemia-induced insulin resistance in the liver in type 2 diabetes
复制标题
Egr-1转录激活蛋白磷酸酶PTP1B以促进2型糖尿病患者肝脏中高胰岛素血症诱导的胰岛素抵抗
DOI:
10.1002/1873-3468.13537
复制
发表时间:
2019
期刊:
影响因子:
3.5
通讯作者:
Li Chaojun
中科院分区:
文献类型:
--
作者:
Wu Jing;Tao Weiwei;Bu D;an;Zhao Yue;Zhang Tongyu;Chong Danyang;Xue Bin;Xing Zheng;Li Chaojun
During the development of type 2 diabetes mellitus (T2DM), hyperinsulinemia is the earliest symptom. It is believed that long‐term high insulin stimulation might facilitate insulin resistance in the liver, but the underlying mechanism remains unknown. Herein, we report that hyperinsulinemia could induce persistent early growth response gene‐1 (Egr‐1) activation in hepatocytes, which provides negative feedback inhibition of insulin sensitivity by inducing the expression of protein tyrosine phosphatase‐1B (PTP1B). Deletion of Egr‐1 in the liver remarkably decreases glucose production, thus improving systemic glucose tolerance and insulin sensitivity. Mechanistic analysis indicates that Egr‐1 inhibits insulin receptor phosphorylation by directly activating PTP1B transcription in the liver. Our results reveal the molecular mechanism by which hyperinsulinemia accelerates insulin resistance in hepatocytes during the progression of T2DM.